Article metrics

Download PDFPDF

Original research
Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer

 

Online download statistics by month:

Online download statistics by month: May 2020 to September 2024

AbstractFullPdf
May 202010210251
Jun 2020186186194
Jul 2020808053
Aug 2020464665
Sep 2020686822
Oct 2020767552
Nov 2020575718
Dec 2020717122
Jan 202110710760
Feb 202110710735
Mar 202114314335
Apr 202110210233
May 2021777742
Jun 2021797937
Jul 2021676732
Aug 2021575735
Sep 2021484847
Oct 2021515146
Nov 2021525231
Dec 2021454612
Jan 2022454819
Feb 2022131317
Mar 2022667233
Apr 2022525432
May 2022657135
Jun 2022414126
Jul 2022646633
Aug 2022505045
Sep 2022525667
Oct 2022545423
Nov 2022505228
Dec 2022373711
Jan 2023323218
Feb 2023757621
Mar 2023272813
Apr 2023282817
May 2023282816
Jun 2023232314
Jul 2023242416
Aug 2023696956
Sep 2023232310
Oct 2023222211
Nov 2023454615
Dec 2023303028
Jan 2024404112
Feb 2024454624
Mar 2024323350
Apr 2024202126
May 2024394132
Jun 2024252522
Jul 2024434421
Aug 2024232311
Sep 2024212123
Total292429591747